stockrowNovo Nordisk A/S
NVO Healthcare Drug Manufacturers General
Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.
- Revenue
- +4.47%
- EPS
- −18.7%
- Free cash flow
- +71.6%
- Total debt
- +44.4%
Quarter to June 2026, against a year earlier
Follow NVO
Alert me
Novo Nordisk A/S (NVO) Operating margin
Novo Nordisk A/S's operating margin over the twelve months to 30 June 2026 was 43.4%, up 2.1 percentage points from fiscal 2025 (41.3%). Over the past ten years it has ranged from 41.3% (fiscal 2025) to 45.8% (fiscal 2015) — the current reading is the lowest in ten years. That is above the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 41.3% | (2.89) |
| FY2024 | 44.2% | 0.03 |
| FY2023 | 44.2% | 1.88 |
| FY2022 | 42.3% | 0.63 |
| FY2021 | 41.7% | (0.99) |
| FY2020 | 42.6% | (0.37) |
| FY2019 | 43.0% | 0.76 |
| FY2018 | 42.3% | (1.59) |
| FY2017 | 43.8% | 0.51 |
| FY2016 | 43.3% | (2.48) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 34.5% | (27.09) |
| Mar 2026 | 61.6% | 20.59 |
| Dec 2025 | 41.0% | 9.39 |
| Sep 2025 | 31.6% | (11.93) |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi compare | 18.7% |
| GSK GSK PLC Sponsored ADR compare | 18.0% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on NVO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement